Akbarzadeh Gohar, Abedi Parvin, Jahanfar Shayesteh, Mansurkhani Hossein Sadeghi, Fakhri Ahmad, Maraghi Elham
Midwifery Department, Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Midwifery Department, Menopause Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Front Med (Lausanne). 2024 Dec 5;11:1466341. doi: 10.3389/fmed.2024.1466341. eCollection 2024.
Sexual dysfunction is prevalent among breastfeeding women.
This study was designed to evaluate the effect of Rose damascene extract on sexual function and anxiety of breastfeeding women.
This was a randomized controlled trial. This study was conducted on 87 breastfeeding women who received either Rose damascene ( = 44) or placebo ( = 43) for eight weeks. The primary outcomes were sexual function and anxiety. A demographic questionnaire, and obstetric questionnaire, the Female Sexual Function Scale (FSFI), and the Spielberger questionnaire were used to collect the data. Chi-square test, independent -test, and ANCOVA were used to analyze the data.
In the intervention group, there was a significant increase in the scores of sexual desire, arousal, lubrication, orgasm, and sexual satisfaction, while the score of pain reduced significantly after eight weeks of intervention ( < 0.001). The mean total score of sexual function prior to the intervention was 19.61 ± 5.02 and 21.46 ± 3.08 in the intervention and control groups, respectively. After intervention, this score was improved in the intervention group compared to the control group (25.21 ± 1.62 vs. 21.82 ± 3, < 0.001). The pre-intervention score of trait anxiety was 47.97 ± 4.68 and 48.44 ± 5.89 in the intervention and control groups, respectively, which was improved in the intervention group compared to the control group after intervention (51.63 ± 3.53 vs. 48.13 ± 5.57, < 0.001). Although there was an improvement in the score of state anxiety in the intervention group compared to the control group, the difference was not statistically significant (43.31 ± 6.41 vs. 44.30 ± 8.87, = 0.397).
Rose damascene could significantly improve the sexual functions of breastfeeding women. It also decreased the trait anxiety but failed to improve the state anxiety significantly. Using this herb is recommended to enhance sexual performance in breastfeeding women.
https://www.irct.ir/trial/61375, identifier IRCT20211015052775N1.
性功能障碍在哺乳期女性中很普遍。
本研究旨在评估大马士革玫瑰提取物对哺乳期女性性功能和焦虑的影响。
这是一项随机对照试验。本研究对87名哺乳期女性进行，她们被分为两组，分别接受大马士革玫瑰提取物（n = 44）或安慰剂（n = 43）治疗，为期八周。主要观察指标为性功能和焦虑。使用人口统计学问卷、产科问卷、女性性功能量表（FSFI）和斯皮尔伯格问卷收集数据。采用卡方检验、独立样本t检验和协方差分析进行数据分析。
干预组在干预八周后，性欲、性唤起、阴道润滑、性高潮和性满意度得分显著增加，疼痛得分显著降低（P < 0.001）。干预前，干预组和对照组的性功能总平均分分别为19.61 ± 5.02和21.46 ± 3.08。干预后，干预组的该得分相比对照组有所改善（25.21 ± 1.62 vs. 21.82 ± 3，P < 0.001）。干预前，干预组和对照组的特质焦虑得分分别为47.97 ± 4.68和48.44 ± 5.89，干预后，干预组的该得分相比对照组有所改善（51.63 ± 3.53 vs. 48.13 ± 5.57，P < 0.001）。虽然干预组的状态焦虑得分相比对照组有所改善，但差异无统计学意义（43.31 ± 6.41 vs. 44.30 ± 8.87，P = 0.397）。
大马士革玫瑰能显著改善哺乳期女性的性功能，还能降低特质焦虑，但未能显著改善状态焦虑。建议使用这种草药来提高哺乳期女性的性表现。
